{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T09:02:27Z","timestamp":1789722147747,"version":"4.0.1"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005111","name":"Copenhagen University Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005111","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100030732","name":"MSD","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100030732","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.atherosclerosis.2026.120757","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:19:11Z","timestamp":1779668351000},"page":"120757","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Lipid clinics worldwide: harmonization and guidance on how to optimally organize and fund. European Atherosclerosis Society consensus statement across 55 countries and more than 500 lipid clinics"],"prefix":"10.1016","volume":"418","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5233-2902","authenticated-orcid":false,"given":"Christian","family":"Bork","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1954-7220","authenticated-orcid":false,"given":"B\u00f8rge G.","family":"Nordestgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berit Storgaard","family":"Hedegaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Vrablik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsie","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Freiberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zlatko","family":"Fras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Nanchen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fouzia","family":"Sadiq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kausik K.","family":"Ray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"Holven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanine E.","family":"Roeters van Lennep","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Laufs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Benn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoaib","family":"Afzal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelos","family":"Liberopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katariina","family":"\u00d6\u00f6rni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meral","family":"Kayikcioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mutaz","family":"Al-Khnifsawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid","family":"Al-Rasadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lambert Tetteh","family":"Appiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makhabbat","family":"Bekbossynova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph J.","family":"Binder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1xima M\u00e9ndez","family":"Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariia","family":"Cherska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Chlebus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Corral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronen","family":"Durst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marat","family":"Ezhov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Gaita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Galimberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Gaudet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tea","family":"Gamezardashvili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel Alberto","family":"Garc\u00eda-Pe\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urh","family":"Groselj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariko","family":"Harada-Shiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio Emanuel","family":"Kaiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavs","family":"Latkovskis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Maher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winfried","family":"M\u00e4rz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Llu\u00eds","family":"Masana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Thushara","family":"Matthias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Mertens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olena","family":"Mitchenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam J.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Nicholls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard C.","family":"O'Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belma","family":"Pojskic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gy\u00f6rgy","family":"Paragh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaneta","family":"Petrulioniene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arman","family":"Postadzhiyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick J.","family":"Raal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashraf","family":"Reda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ximena","family":"Reyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u017deljko","family":"Reiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Romeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos A.","family":"Aguilar Salinas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik S.","family":"Stroes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phivos","family":"Symeonides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandr B.","family":"Shek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Mello e Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tigist","family":"Mekonnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myra","family":"Tilney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lale","family":"Tokgozoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandros D.","family":"Tselepis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margus","family":"Viigimaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Branislav","family":"Vohnout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luz Clemencia","family":"Zarate-Correa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Moulin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2026.120757_bib1","unstructured":"European Commission. The EU Cardiovascular Health Plan (Safe Hearts Plan), 2025."},{"key":"10.1016\/j.atherosclerosis.2026.120757_bib2","unstructured":"Webpage: https:\/\/datatopics.worldbank.org\/world-development-indicators\/the-world-by-income-and-region.html.TWB."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120757_bib3","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.atherosclerosis.2026.120757_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2025.120479","article-title":"2025 Focused Update of the 2019 ESC\/EAS Guidelines for the management of dyslipidaemias","volume":"409","author":"Mach","year":"2025","journal-title":"Atherosclerosis"},{"issue":"16","key":"10.1016\/j.atherosclerosis.2026.120757_bib5","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1093\/eurheartj\/ehac605","article-title":"High-density lipoprotein revisited: biological functions and clinical relevance","volume":"44","author":"von Eckardstein","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.atherosclerosis.2026.120757_bib6","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.atherosclerosis.2023.04.003","article-title":"Genetic testing increases the likelihood of a diagnosis of familial hypercholesterolaemia among people referred to lipid clinics: danish national study","volume":"373","author":"Hedegaard","year":"2023","journal-title":"Atherosclerosis"},{"issue":"36","key":"10.1016\/j.atherosclerosis.2026.120757_bib7","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1093\/eurheartj\/ehv157","article-title":"Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment","volume":"36","author":"Wiegman","year":"2015","journal-title":"Eur Heart J"},{"issue":"32","key":"10.1016\/j.atherosclerosis.2026.120757_bib8","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1093\/eurheartj\/ehu274","article-title":"Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society","volume":"35","author":"Cuchel","year":"2014","journal-title":"Eur Heart J"},{"issue":"39","key":"10.1016\/j.atherosclerosis.2026.120757_bib9","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1093\/eurheartj\/ehac361","article-title":"Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement","volume":"43","author":"Kronenberg","year":"2022","journal-title":"Eur Heart J"},{"issue":"21","key":"10.1016\/j.atherosclerosis.2026.120757_bib10","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1016\/j.jacc.2022.09.021","article-title":"Equivalent impact of elevated Lipoprotein(a) and familial hypercholesterolemia in patients with atherosclerotic cardiovascular disease","volume":"80","author":"Hedegaard","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"42","key":"10.1016\/j.atherosclerosis.2026.120757_bib11","doi-asserted-by":"crossref","first-page":"4359","DOI":"10.1093\/eurheartj\/ehaf190","article-title":"2025 Focused Update of the 2019 ESC\/EAS Guidelines for the management of dyslipidaemias","volume":"46","author":"Mach","year":"2025","journal-title":"Eur Heart J"},{"issue":"17","key":"10.1016\/j.atherosclerosis.2026.120757_bib12","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/eurheartj\/ehv043","article-title":"Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management","volume":"36","author":"Stroes","year":"2015","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120757_bib13","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S2213-8587(19)30264-5","article-title":"Rare dyslipidaemias, from phenotype to genotype to management: a European Atherosclerosis Society task force consensus statement","volume":"8","author":"Hegele","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2026.120757_bib14","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"issue":"19","key":"10.1016\/j.atherosclerosis.2026.120757_bib15","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1001\/jama.2013.280532","article-title":"Comparison of a novel method vs the Friedewald equation for estimating low-density lipoprotein cholesterol levels from the standard lipid profile","volume":"310","author":"Martin","year":"2013","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2026.120757_bib16","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1001\/jamacardio.2020.0013","article-title":"A new equation for calculation of low-density lipoprotein cholesterol in patients with normolipidemia and\/or hypertriglyceridemia","volume":"5","author":"Sampson","year":"2020","journal-title":"JAMA Cardiol"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2026.120757_bib17","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1093\/clinchem\/hvaf073","article-title":"A modified Sampson-NIH equation with improved accuracy for estimating low levels of low-density lipoprotein-cholesterol","volume":"71","author":"Sampson","year":"2025","journal-title":"Clin Chem"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.120757_bib18","first-page":"282","article-title":"Methods of low-density lipoprotein-cholesterol measurement: analytical and clinical applications","volume":"33","author":"Islam","year":"2022","journal-title":"EJIFCC"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.120757_bib19","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1515\/cclm-2019-1253","article-title":"Quantifying atherogenic lipoproteins for lipid-lowering strategies: consensus-based recommendations from EAS and EFLM","volume":"58","author":"Langlois","year":"2020","journal-title":"Clin Chem Lab Med"},{"issue":"34","key":"10.1016\/j.atherosclerosis.2026.120757_bib20","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC Guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur Heart J"},{"issue":"32","key":"10.1016\/j.atherosclerosis.2026.120757_bib21","doi-asserted-by":"crossref","first-page":"3178","DOI":"10.1093\/eurheartj\/ehaf274","article-title":"Residual cardiovascular risk beyond low-density lipoprotein cholesterol: inflammation, remnant cholesterol, and lipoprotein(a)","volume":"46","author":"Wulff","year":"2025","journal-title":"Eur Heart J"},{"issue":"25","key":"10.1016\/j.atherosclerosis.2026.120757_bib22","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1093\/eurheartj\/ehw152","volume":"37","author":"Nordestgaard","year":"2016","journal-title":"Eur Heart J"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2026.120757_bib23","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1093\/clinchem\/hvae046","article-title":"Worldwide increasing use of nonfasting rather than fasting lipid profiles","volume":"70","author":"Langsted","year":"2024","journal-title":"Clin Chem"},{"issue":"10459","key":"10.1016\/j.atherosclerosis.2026.120757_bib24","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0140-6736(24)01308-4","article-title":"Lipoprotein(a) and cardiovascular disease","volume":"404","author":"Nordestgaard","year":"2024","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2026.120757_bib25","first-page":"1129","article-title":"2021 Canadian Cardiovascular Society Guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in adults","volume":"37","author":"Pearson","year":"2021","journal-title":"Can J Cardiol"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.120757_bib26","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1210\/clinem\/dgad625","article-title":"High Lipoprotein(a) May explain one-quarter of clinical familial hypercholesterolemia diagnoses in Danish lipid clinics","volume":"109","author":"Hedegaard","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2026.120757_bib27","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S2213-8587(16)30042-0","article-title":"High lipoprotein(a) as a possible cause of clinical familial hypercholesterolaemia: a prospective cohort study","volume":"4","author":"Langsted","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"25","key":"10.1016\/j.atherosclerosis.2026.120757_bib28","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1093\/eurheartj\/ehad197","article-title":"2023 update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance","volume":"44","author":"Cuchel","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.atherosclerosis.2026.120757_bib29","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.atherosclerosis.2019.12.005","article-title":"Quantifying atherogenic lipoproteins for lipid-lowering strategies: Consensus-based recommendations from EAS and EFLM","volume":"294","author":"Nordestgaard","year":"2020","journal-title":"Atherosclerosis"},{"issue":"32","key":"10.1016\/j.atherosclerosis.2026.120757_bib30","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel","volume":"38","author":"Ference","year":"2017","journal-title":"Eur Heart J"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2026.120757_bib31","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.jacc.2021.01.027","article-title":"Apolipoprotein B and Non-HDL cholesterol better reflect residual risk than LDL cholesterol in Statin-Treated patients","volume":"77","author":"Johannesen","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.120757_bib32","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1001\/jamacardio.2021.5083","article-title":"Association of Apolipoprotein B-Containing lipoproteins and risk of myocardial infarction in individuals with and without atherosclerosis: distinguishing between particle concentration, type, and content","volume":"7","author":"Marston","year":"2022","journal-title":"JAMA Cardiol"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2026.120757_bib33","doi-asserted-by":"crossref","first-page":"845","DOI":"10.26599\/1671-5411.2023.12.001","article-title":"Discordance analysis for apolipoprotein and lipid measures for predicting myocardial infarction in statin-treated patients with coronary artery disease: a cohort study","volume":"20","author":"Li","year":"2023","journal-title":"J Geriatr Cardiol"},{"issue":"27","key":"10.1016\/j.atherosclerosis.2026.120757_bib34","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1093\/eurheartj\/ehae258","article-title":"Discordance among apoB, non-high-density lipoprotein cholesterol, and triglycerides: implications for cardiovascular prevention","volume":"45","author":"Sniderman","year":"2024","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.120757_bib35","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jacl.2020.04.011","article-title":"Genetic testing in dyslipidemia: a scientific statement from the National Lipid Association","volume":"14","author":"Brown","year":"2020","journal-title":"J Clin Lipidol"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.120757_bib36","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.gim.2021.09.012","article-title":"The Clinical Genome Resource (ClinGen) Familial Hypercholesterolemia Variant Curation Expert Panel consensus guidelines for LDLR variant classification","volume":"24","author":"Chora","year":"2022","journal-title":"Genet Med"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2026.120757_bib37","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/s41431-022-01091-0","article-title":"Recommendations for reporting results of diagnostic genomic testing","volume":"30","author":"Deans","year":"2022","journal-title":"Eur J Hum Genet"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.120757_bib38","doi-asserted-by":"crossref","first-page":"433","DOI":"10.7326\/M22-3027","article-title":"Subclinical coronary atherosclerosis and risk for myocardial infarction in a Danish cohort : a prospective observational cohort Study","volume":"176","author":"Fuchs","year":"2023","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.120757_bib39","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jcct.2020.11.001","article-title":"SCCT 2021 expert consensus document on coronary computed tomographic angiography: a report of the Society of cardiovascular computed tomography","volume":"15","author":"Narula","year":"2021","journal-title":"J Cardiovasc Comput Tomogr"},{"issue":"45","key":"10.1016\/j.atherosclerosis.2026.120757_bib40","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/eht273","article-title":"Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society","volume":"34","author":"Nordestgaard","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.atherosclerosis.2026.120757_bib41","first-page":"zwaf352","article-title":"Proposal of a familial hypercholesterolemia pediatric diagnostic Score (FH-PeDS)","author":"Kafol","year":"2025","journal-title":"Eur J Prev Cardiol"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.120757_bib42","doi-asserted-by":"crossref","first-page":"e703","DOI":"10.1210\/clinem\/dgae259","article-title":"Prevalence of dysbetalipoproteinemia in the UK biobank according to different diagnostic criteria","volume":"110","author":"Paquette","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.atherosclerosis.2026.120757_bib43","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.atherosclerosis.2018.06.814","article-title":"Identification and diagnosis of patients with familial chylomicronaemia syndrome (FCS): expert panel recommendations and proposal of an \"FCS score\"","volume":"275","author":"Moulin","year":"2018","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120757_bib44","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jacl.2024.09.008","article-title":"Development and validation of clinical criteria to identify familial chylomicronemia syndrome (FCS) in North America","volume":"19","author":"Hegele","year":"2025","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.atherosclerosis.2026.120757_bib45","series-title":"Global spending on health: a world in transition","year":"2019"},{"key":"10.1016\/j.atherosclerosis.2026.120757_bib46","series-title":"Global spending on health: emerging from the pandemic","year":"2024"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.120757_bib47","doi-asserted-by":"crossref","DOI":"10.5001\/omj.2024.81","article-title":"Nutritional management of dyslipidemia in Pakistan: a Systematic Review of International Guidelines and practices","volume":"39","author":"Najeeb","year":"2024","journal-title":"Oman Med J"},{"issue":"18","key":"10.1016\/j.atherosclerosis.2026.120757_bib48","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1161\/CIR.0000000000001182","article-title":"Food is medicine: a presidential advisory from the American heart Association","volume":"148","author":"Volpp","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2026.120757_bib49","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-078713","article-title":"Effectiveness of behavioural interventions with motivational interviewing on physical activity outcomes in adults: systematic review and meta-analysis","volume":"386","author":"Zhu","year":"2024","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120757_bib50","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1001\/jamainternmed.2023.6419","article-title":"Association of smoking cessation and cardiovascular, cancer, and respiratory mortality","volume":"184","author":"Thomson","year":"2024","journal-title":"JAMA Intern Med"},{"issue":"9493","key":"10.1016\/j.atherosclerosis.2026.120757_bib51","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","article-title":"Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins","volume":"366","author":"Baigent","year":"2005","journal-title":"Lancet"},{"issue":"21","key":"10.1016\/j.atherosclerosis.2026.120757_bib52","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1056\/NEJMoa1600176","article-title":"Cholesterol lowering in intermediate-risk persons without cardiovascular disease","volume":"374","author":"Yusuf","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2026.120757_bib53","unstructured":"World Health Organization. Report on the technical expert meeting on selection and prioritization of noncommunicable disease primary care facility based indicators."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.120757_bib54","doi-asserted-by":"crossref","first-page":"e369","DOI":"10.1016\/S2214-109X(21)00551-9","article-title":"Use of statins for the prevention of cardiovascular disease in 41 low-income and middle-income countries: a cross-sectional study of nationally representative, individual-level data","volume":"10","author":"Marcus","year":"2022","journal-title":"Lancet Global Health"},{"issue":"10349","key":"10.1016\/j.atherosclerosis.2026.120757_bib55","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S0140-6736(22)00916-3","article-title":"Long-term efficacy and safety of moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease (RACING): a randomised, open-label, non-inferiority trial","volume":"400","author":"Kim","year":"2022","journal-title":"Lancet"},{"issue":"25","key":"10.1016\/j.atherosclerosis.2026.120757_bib56","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","article-title":"Ezetimibe added to Statin therapy after Acute coronary syndromes","volume":"372","author":"Cannon","year":"2015","journal-title":"N Engl J Med"},{"issue":"25","key":"10.1016\/j.atherosclerosis.2026.120757_bib57","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 Study","volume":"76","author":"Roth","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.120757_bib58","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1056\/NEJMe1306987","article-title":"Do lifestyle changes reduce serious outcomes in diabetes?","volume":"369","author":"Gerstein","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2026.120757_bib59","series-title":"HEARTS technical package for cardiovascular disease management in primary health care","year":"2020"},{"key":"10.1016\/j.atherosclerosis.2026.120757_bib60","series-title":"WHO model list of essential medicines. 23rd list","year":"2023"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2026.120757_bib61","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/s41569-019-0325-8","article-title":"Familial hypercholesterolaemia: evolving knowledge for designing adaptive models of care","volume":"17","author":"Watts","year":"2020","journal-title":"Nat Rev Cardiol"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120757_bib62","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1812792","article-title":"Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia","volume":"380","author":"Bhatt","year":"2019","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.120757_bib63","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1161\/CIRCULATIONAHA.120.048026","article-title":"Number of social determinants of health and fatal and nonfatal incident coronary heart disease in the REGARDS Study","volume":"143","author":"Safford","year":"2021","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2026.120757_bib64","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph13101039","article-title":"Tobacco control progress in low and middle income countries in comparison to high income countries","volume":"13","author":"Anderson","year":"2016","journal-title":"Int J Environ Res Publ Health"},{"issue":"10059","key":"10.1016\/j.atherosclerosis.2026.120757_bib65","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1016\/S0140-6736(16)31357-5","article-title":"Interpretation of the evidence for the efficacy and safety of statin therapy","volume":"388","author":"Collins","year":"2016","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.120757_bib66","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.48172","article-title":"Cost-effectiveness of icosapent ethyl for high-risk patients with hypertriglyceridemia despite Statin treatment","volume":"5","author":"Weintraub","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2026.120757_bib67","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.amjcard.2016.11.025","article-title":"Value of the definition of severe familial hypercholesterolemia for stratification of heterozygous patients","volume":"119","author":"Perez-Calahorra","year":"2017","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.120757_bib68","doi-asserted-by":"crossref","first-page":"e1332","DOI":"10.1210\/clinem\/dgaa838","article-title":"10-Year comparative Follow-up of familial versus multifactorial chylomicronemia syndromes","volume":"106","author":"Belhassen","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2026.120757_bib69","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.jacc.2021.07.022","article-title":"Side effect patterns in a crossover trial of Statin, placebo, and no treatment","volume":"78","author":"Howard","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2026.120757_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2025.100993","article-title":"Implementation strategies for improving the care of familial hypercholesterolaemia from the International Atherosclerosis Society: next steps in implementation science and practice","volume":"22","author":"Sarkies","year":"2025","journal-title":"Am J Prev Cardiol"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120757_bib71","article-title":"Familial hypercholesterolemia: a comprehensive review of advances in treatment strategies and the role of patient beliefs","volume":"17","author":"Bakour","year":"2025","journal-title":"Cureus"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2026.120757_bib72","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph20105878","article-title":"Challenges in improving adherence to diet and drug treatment in hypercholesterolemia patients","volume":"20","author":"Baratta","year":"2023","journal-title":"Int J Environ Res Publ Health"},{"key":"10.1016\/j.atherosclerosis.2026.120757_bib73","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2147\/VHRM.S158641","article-title":"Nonadherence to statins: individualized intervention strategies outside the pill box","volume":"14","author":"Lansberg","year":"2018","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.atherosclerosis.2026.120757_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2022.100344","article-title":"Patient experiences align with the familial hypercholesterolemia global call to action","volume":"10","author":"Jones","year":"2022","journal-title":"Am J Prev Cardiol"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2026.120757_bib75","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.124.038458","article-title":"Life course approach for managing familial hypercholesterolemia","volume":"14","author":"Gidding","year":"2025","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.120757_bib76","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.37765\/ajmc.2025.89682","article-title":"Longer appointment duration reduces future missed appointments in safety-net clinics","volume":"31","author":"Adepoju","year":"2025","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.atherosclerosis.2026.120757_bib77","doi-asserted-by":"crossref","DOI":"10.1108\/JHOM-11-2021-0425","article-title":"Causes, impacts and possible mitigation of non-attendance of appointments within the National Health Service: a literature review","author":"Wilson","year":"2022","journal-title":"J Health Organisat Manag"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120757_bib78","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1186\/s12913-024-10947-8","article-title":"Identifying barriers to outpatient appointment attendance in patient groups at risk of inequity: a mixed methods study in a London NHS trust","volume":"24","author":"Sung","year":"2024","journal-title":"BMC Health Serv Res"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2026.120757_bib79","article-title":"Interventions to improve adherence to lipid-lowering medication","volume":"12","author":"van Driel","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.atherosclerosis.2026.120757_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2025.120463","article-title":"Clinical familial hypercholesterolemia, heart healthy dietary adherence, and cardiovascular risk","volume":"408","author":"Toft-Nielsen","year":"2025","journal-title":"Atherosclerosis"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2026.120757_bib81","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-030290","article-title":"Enablers and barriers to treatment adherence in heterozygous familial hypercholesterolaemia: a qualitative evidence synthesis","volume":"9","author":"Kinnear","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.atherosclerosis.2026.120757_bib82","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.atherosclerosis.2018.08.020","article-title":"Familial hypercholesterolaemia patient support groups and advocacy: a multinational perspective","volume":"277","author":"Payne","year":"2018","journal-title":"Atherosclerosis"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915026001231?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915026001231?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T06:31:04Z","timestamp":1785911464000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915026001231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":82,"alternative-id":["S0021915026001231"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2026.120757","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipid clinics worldwide: harmonization and guidance on how to optimally organize and fund. European Atherosclerosis Society consensus statement across 55 countries and more than 500 lipid clinics","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2026.120757","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"120757"}}